NovMetaPharma Market Cap

NovMetaPharma has a market cap or net worth of 151.5 billion as of January 29, 2026. Its market cap has increased by 165.77% in one year.

Market Cap

151.50B

Enterprise Value

n/a

Revenue

1.30B

Ranking

n/a

PE Ratio

99.33

Stock Price

11,920.00

Market Cap Chart

Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 151.50B, an increase of 103.11%. That is a compound annual growth rate of 8.36%.

Market Cap History

Date	Market Cap	% Change
Jan 28, 2026	152.52B	-6.83%
Dec 30, 2025	163.69B	187.16%
Dec 30, 2024	57.00B	-46.33%
Dec 29, 2022	106.21B	-45.89%
Dec 30, 2021	196.29B	-9.50%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ensol Biosciences	215.61B
Kangstem Biotech	198.45B
Bio Solution	192.65B
curacle co.,ltd.	186.56B
ViGenCell	172.60B
QuadMedicine	167.40B
CORESTEMCHEMON	162.58B
TiumBio	159.56B

Market Cap Rankings